Literature DB >> 32116112

Oncogenic hsa_circ_0091581 promotes the malignancy of HCC cell through blocking miR-526b from degrading c-MYC mRNA.

Xiaolin Wei1, Wenjing Zheng1, Peikai Tian1, Yong He1, Hui Liu1, Minjie Peng1, Xiaowu Li1, Xiangde Liu2.   

Abstract

Circular RNAs (circRNAs) are new types of endogenous non-coding RNAs, which are identified to have critical regulatory roles in cancer biology. In this study, we aimed to find the abnormally expressed circRNAs in hepatocellular carcinoma (HCC) and investigate the function and mechanism of circRNAs in HCC progression. Upregulation of hsa_circ_0091581 was identified by RNA-sequencing and validated by quantitative real-time polymerase chain reaction (qRT-PCR). Hsa_circ_0091581 expression was correlated with tumor size, disease-free survial and overall survival of HCC patients. Functionally, hsa_circ_0091581 could promote the proliferation of HCC cells in vitro. Mechanism research showed that hsa_circ_0091581 promoted cell proliferation via hsa_circ_0091581/miR-526b/c-Myc axis in HCC cells. Also, the expression of hsa_circ_0091581 in HCC could be regulated by c-Myc. These results revealed that hsa_circ_0091581/miR-526b/c-Myc/hsa_circ_0091581 positive feedback loop plays a vital role in HCC progression and hsa_circ_0091581 may be a potential prognostic biomarker and therapeutic target for HCC.

Entities:  

Keywords:  Circular RNA; c-Myc; hepatocellular carcinoma; miR-526b

Year:  2020        PMID: 32116112      PMCID: PMC7145323          DOI: 10.1080/15384101.2020.1731945

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  13 in total

1.  Differentiating early and late recurrences after resection of HCC in cirrhotic patients: implications on surveillance, prevention, and treatment strategies.

Authors:  Ronnie T P Poon
Journal:  Ann Surg Oncol       Date:  2009-02-04       Impact factor: 5.344

Review 2.  The emerging functions and roles of circular RNAs in cancer.

Authors:  Shibin Qu; Zhengcai Liu; Xisheng Yang; Jingshi Zhou; Hengchao Yu; Rui Zhang; Haimin Li
Journal:  Cancer Lett       Date:  2017-11-22       Impact factor: 8.679

3.  Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma.

Authors:  Li Li; Ronghua Jin; Xiaoli Zhang; Fudong Lv; Lifeng Liu; Daojie Liu; Kai Liu; Ning Li; Dexi Chen
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

Review 4.  Surgical treatment for hepatocellular carcinoma.

Authors:  Tadatoshi Takayama
Journal:  Jpn J Clin Oncol       Date:  2011-03-16       Impact factor: 3.019

5.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

6.  Detecting and characterizing circular RNAs.

Authors:  William R Jeck; Norman E Sharpless
Journal:  Nat Biotechnol       Date:  2014-05       Impact factor: 54.908

Review 7.  Translocations involving c-myc and c-myc function.

Authors:  L M Boxer; C V Dang
Journal:  Oncogene       Date:  2001-09-10       Impact factor: 9.867

8.  Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.

Authors:  Jian Yu; Qing-Guo Xu; Zhen-Guang Wang; Yuan Yang; Ling Zhang; Jin-Zhao Ma; Shu-Han Sun; Fu Yang; Wei-Ping Zhou
Journal:  J Hepatol       Date:  2018-01-31       Impact factor: 25.083

9.  Cancer treatment and survivorship statistics, 2016.

Authors:  Kimberly D Miller; Rebecca L Siegel; Chun Chieh Lin; Angela B Mariotto; Joan L Kramer; Julia H Rowland; Kevin D Stein; Rick Alteri; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-06-02       Impact factor: 508.702

10.  microRNA-526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma.

Authors:  Xin Liu; Liu Yang; Jianfeng Tu; Wenwei Cai; Meiqi Zhang; Zhangxuan Shou; Yingmin Yao; Qiuran Xu
Journal:  Oncotarget       Date:  2017-09-23
View more
  14 in total

1.  Silencing CircEIF3I/miR-526b-5p Axis Epigenetically Targets HGF/c-Met Signal to Hinder the Malignant Growth, Metastasis and Angiogenesis of Hepatocellular Carcinoma.

Authors:  Yang Liu; Xia Xiao; Jingying Wang; Yitong Wang; Yanhui Yu
Journal:  Biochem Genet       Date:  2022-06-20       Impact factor: 1.890

Review 2.  Circular RNAs in hepatocellular carcinoma: Recent advances.

Authors:  Zhao-Shan Niu; Wen-Hong Wang
Journal:  World J Gastrointest Oncol       Date:  2022-06-15

3.  CircRNA circUGGT2 Contributes to Hepatocellular Carcinoma Development via Regulation of the miR-526b-5p/RAB1A Axis.

Authors:  Qingling Kong; Qing Fan; Xianbin Ma; Jian Li; Rong Ma
Journal:  Cancer Manag Res       Date:  2020-10-15       Impact factor: 3.989

Review 4.  Circular RNAs in Hepatocellular Carcinoma: Emerging Functions to Clinical Significances.

Authors:  Yucheng Zhang; Yali Wang
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

5.  Hsa_circ_0091581 promotes glioma progression by regulating RMI1 via sponging miR-1243-5p.

Authors:  Jin Qian; Yingna Xu; Xing Xu; Zhenyu Tao; Yang Luo; Yichang Xu; Yong Zhang; Chunfa Qian
Journal:  J Cancer       Date:  2021-04-02       Impact factor: 4.207

6.  CircCBFB is a mediator of hepatocellular carcinoma cell autophagy and proliferation through miR-424-5p/ATG14 axis.

Authors:  Zidan Zhao; Junjian He; Chao Feng
Journal:  Immunol Res       Date:  2022-01-23       Impact factor: 2.829

7.  Circ_LDLR Knockdown Suppresses Progression of Hepatocellular Carcinoma via Modulating miR-7/RNF38 Axis.

Authors:  Yuming Jia; Shengchao Li; Meng Zhang; Zhilei Zhang; Chao Wang; Chong Zhang; Wuhan Yang; Li Peng; Zhuo Xu
Journal:  Cancer Manag Res       Date:  2021-01-13       Impact factor: 3.989

8.  CircAMOTL1 Promotes Tumorigenesis Through miR-526b/SIK2 Axis in Cervical Cancer.

Authors:  Zhengwei Sun; Sanqiang Niu; Fuxia Xu; Weidong Zhao; Rong Ma; Mingwei Chen
Journal:  Front Cell Dev Biol       Date:  2020-12-03

Review 9.  Circular RNA is a popular molecule in tumors of the digestive system (Review).

Authors:  Hao-Ying Wang; Yu-Ping Wang; Xi Zeng; Ya Zheng; Qing-Hong Guo; Rui Ji; Yong-Ning Zhou
Journal:  Int J Oncol       Date:  2020-04-27       Impact factor: 5.650

Review 10.  Circular RNAs in gastrointestinal cancer: Current knowledge, biomarkers and targeted therapy (Review).

Authors:  Xiaorui Zhao; Yue Wang; Qiongfang Yu; Pei Yu; Qiaoyu Zheng; Xue Yang; Dian Gao
Journal:  Int J Mol Med       Date:  2020-09-16       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.